Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia have?
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia has 24 citations in the OpenAlex counts ScholarIQ stores.
When was Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia published?
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia has 2019 year in the ScholarIQ index.
What is the open-access status of Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia?
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia has diamond oa status in the ScholarIQ index.
What is the DOI of Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia?
The DOI for Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia is on the source record.
What is the PMID of Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia?
The PMID for Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia is on the source record.
What is the OpenAlex record for Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia?
The OpenAlex for Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia is on the source record.